Immuneering Corp (IMRX): 21 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jun 16, 2026 | Hall Brett Matthew Officer | 6,035 | $4.15 | $25.0K | no history |
| Jan 21, 2026 | Brakewood Harold Eugene Officer | 5,250 | $4.76 | $25.0K | no history |
| Jan 20, 2026 | Schall Thomas J. Director | 21,645 | $4.67 | $101.1K | no history |
| Jan 16, 2026 | Hall Brett Matthew Officer | 2,298 | $4.57 | $10.5K | no history |
| Jan 15, 2026 | Neufeld Leah R Officer | 2,626 | $4.15 | $10.9K | no history |
| Jan 14, 2026 | Feinberg Peter Director | 20,000 | $4.35 | $87.0K | no history |
| Oct 7, 2025 | Feinberg Peter Director | 7,500 | $6.67 | $50.0K | no history |
| Oct 2, 2025 | Bookman Michael Officer | 1,020 | $6.83 | $7.0K | no history |
| Oct 2, 2025 | Neufeld Leah R Officer | 800 | $6.38 | $5.1K | no history |
| Oct 2, 2025 | Morales Mallory Officer | 300 | $6.39 | $1.9K | no history |
| Oct 1, 2025 | Feinberg Peter Director | 7,500 | $7.03 | $52.7K | no history |
| Sep 30, 2025 | Feinberg Peter Director | 5,000 | $7.18 | $35.9K | no history |
| Jul 7, 2025 | Neufeld Leah R Officer | 700 | $3.57 | $2.5K | no history |
| Jul 7, 2025 | Hausman Diana Director | 5,500 | $3.61 | $19.9K | no history |
| Jul 3, 2025 | Zeskind Benjamin J. Director, Officer, TenPercentOwner | 10,000 | $3.49 | $34.9K | no history |
| Jun 30, 2025 | Schall Thomas J. Director | 9,500 | $3.66 | $34.8K | no history |
| Jun 24, 2025 | Brakewood Harold Eugene Officer | 1,900 | $2.53 | $4.8K | no history |
| Jun 24, 2025 | Hall Brett Matthew Officer | 13,422 | $2.58 | $34.6K | no history |
| Jun 23, 2025 | Feinberg Peter Director | 25,000 | $2.53 | $63.2K | no history |
| Jun 20, 2025 | Zeskind Benjamin J. Director, Officer, TenPercentOwner | 21,000 | $2.39 | $50.2K | no history |
| Jun 18, 2025 | Schall Thomas J. Director | 40,485 | $2.21 | $89.5K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.